Optima Medical Innovations Corp. (OMIC)

Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)

20.01

0.00 (0.00%)

Inactive · Last trade price on Feb 20, 2025

Singular Genomics Systems Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '21 Sep 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Revenue	1.94	4.61	5.37	0.73	0.39	0.48
Revenue Growth	-72.87%	-14.09%	633.40%	85.81%	-18.05%	-
Gross Profit	0.39	1.38	1.71	-0.03	0.14	0.04
Operating Income	0.18	-2.29	-6.94	-7.79	-5.62	-1.14
Net Income	-0.37	-3.96	-17.63	-15.7	-5.86	-1.23
Earnings Per Share	-0.01	-0.08	-0.41	-1.10	-0.97	-0.49
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '21 Sep 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Cash & Investments	0	0.11	0.06	1.47	0.02	0.01
Total Debt	1.3	1.35	2.25	0.57	0.02	1.28
Net Cash (Debt)	-1.3	-1.24	-2.19	0.9	0.01	-1.27
Net Cash Growth	-	-	-	14559.95%	-	-
Net Cash Per Share	-0.03	-0.03	-0.05	0.06	0.00	-0.51

Cash Flow & CapEx

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '21 Sep 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Operating Cash Flow	0.21	-0.3	-2.18	-1.78	-1.45	-0.7
Capital Expenditures	-0.01	-0.01	-0.25	-0.3	-0.3	-
Free Cash Flow	0.21	-0.31	-2.43	-2.09	-1.75	-0.7
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '21 Sep 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Gross Margin	20.19%	29.93%	31.87%	-3.80%	34.89%	7.61%
Operating Margin	9.29%	-49.59%	-129.19%	-1064.40%	-1424.87%	-237.12%
Pretax Margin	-18.81%	-85.86%	-328.33%	-2144.60%	-1487.38%	-254.89%
Profit Margin	-18.81%	-85.86%	-328.33%	-2144.60%	-1487.38%	-254.89%
FCF Margin	10.61%	-6.72%	-45.24%	-284.82%	-443.41%	-144.77%

Valuation

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Aug '26 Aug 18, 2026	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
PS Ratio	0.00	0.39	1.18	44.94	-	-